Close Menu

BOSTON (GenomeWeb News) – Research collaborations, transparency, and data in the public domain are essential to new drug development, according to a structural biologist who spoke at the American Association for the Advancement of Science meeting here on Saturday.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Newsweek discusses the privacy issues raised by digital medicine.

A group of statisticians wants to eliminate researchers' reliance on 'statistical significance,' according to NPR.

In Nature this week: genetic analysis of Anatolian farmers, cotton genome analysis, and more.

Matt Hancock, the UK health secretary, is calling for the swift rollout of predictive genetic tests, the Guardian reports.